Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases

Experimental Physiology

Volumn 96, Issue 3, 2011, Pages 287-294

  Ferreira, Anderson J ^a,b   Shenoy, Vinayak ^b   Qi, Yanfei ^b   Fraga Silva, Rodrigo A ^b   Santos, Robson A S ^a   Katovich, Michael J ^b   Raizada, Mohan K ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 DIMETHYLAMINO)ETHYLAMINO] 4 (HYDROXYMETHYL) 7 [(4-METHYLPHENYL) SULFONYL OXY] 9H XANTHENE 9 ONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ENZYME ACTIVATOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROXYPROLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART MUSCLE FIBROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WISTAR KYOTO RAT;

EID: 79951509062     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.055277     Document Type: Article

References (24)

1. Bader M, Peters J, Baltatu O, Müller DN, Luft FC & Ganten D (2001). Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79, 76-102.
2. Díez-Freire C, Vázquez J, Correa de Adjounian MF, Ferrari MF, Yuan L, Silver X, Torres R & Raizada MK (2006). ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol Genomics 27, 12-19.
3. Ferreira AJ, Santos RAS, Bradford CN, Mecca AP, Sumners C, Katovich MJ & Raizada MK (2010). Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 55, 207-213.
4. Ferreira AJ, Shenoy V, Yamazato Y, Sriramula S, Francis J, Yuan L, Castellano RK, Ostrov DA, Oh SP, Katovich MJ & Raizada MK (2009). Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med 179, 1048-1054.
5. Gallagher PE, Ferrario CM & Tallant EA (2008). Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 295, H2373-H2379.
6. Gonzalez A, Lopez B, Querejeta R & Diez J (2002). Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? J Mol Cell Cardiol 34, 1585-1593.
7. Grobe JL, Mecca AP, Mao H & Katovich MJ (2006). Chronic angiotensin-(1-7) prevents cardiac fibrosis in the DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 290, H2417-H2423.
8. Hernández Prada JA, Ferreira AJ, Katovich MJ, Shenoy V, Qi Y, Santos RAS, Castellano RK, Lampkins AJ, Gubala V, Ostrov DA & Raizada MK (2008). Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension 51, 1312-1317.
9. Huentelman MJ, Grobe JL, Vazquez J, Stewart JM, Mecca AP, Katovich MJ, Ferrario CM & Raizada MK (2005). Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2. Exp Physiol 90, 783-790.
10. Huentelman MJ, Zubcevic J, Katovich MJ & Raizada MK (2004). Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. Regul Pep 122, 61-67.
11. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX & Greenberg BH (2005). Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 289, H2356-H2363.
12. Katovich MJ, Grobe JL & Raizada MK (2008). Angiotensin-(1-7) as an antihypertensive, antifibrotic target. Curr Hypertens Rep 10, 227-232.
13. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE & Hsueh WA (2000). Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 101, 1130-1137.
14. Leask A (2010). Potential therapeutic targets for cardiac fibrosis: TGFβ, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 106, 1675-1680.
15. Lehr HA, Mankoff DA, Corwin D, Santeusanio G & Gown AM (1997). Application of Photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45, 1559-1565.
16. Mehta PK & Griendling KK (2007). Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292, C82-C97.
17. Qi Y, Liu X, Li H, Shenoy V, Li Q, Hauswirth WW, Sumners C & Katovich MJ (2010). Selective tropism of the recombinant adeno-associated virus 9 serotype for rat cardiac tissue. J Gene Med 12, 22-34.
18. 1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63, 423-432.
19. Sampaio WO, Castro CH, Santos RAS, Schiffrin EL & Touyz RM (2007). Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50, 1093-1098.
20. Santos RAS, Castro CH, Gava E, Pinheiro SV, Almeida AP, Paula RD, Cruz JS, Ramos AS, Rosa KT, Irigoyen MC, Bader M, Alenina N, Kitten GT & Ferreira AJ (2006). Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor Mas knockout mice. Hypertension 47, 996-1002.
21. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G & Turner AJ (2000). A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275, 33238-33243.
22. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A & Tummino P (2002). Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277, 14838-14843.
23. Weber KT (2000). Fibrosis and hypertensive heart disease. Curr Opin Cardiol 15, 264-272.
24. Yamazato Y, Ferreira AJ, Hong KH, Sriramula S, Francis J, Yamazato M, Yuan L, Bradford CN, Shenoy V, Oh SP, Katovich MJ & Raizada MK (2009). Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer. Hypertension 54, 365-371.